Entegris, Inc. Profile Avatar - Palmy Investing

Entegris, Inc.

Entegris, Inc. develops, manufactures, and supplies microcontamination control products, specialty chemicals, and advanced materials handling solutions in North America, Taiwan, China, South Korea, Japan, Europe, and Southeast Asia. It operates in three …
Semiconductors
US, Billerica [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 24.10 117.62 94.77
Graham Fair Price 9.28 12.42 11.36
PEG -32.76 5.84 8.69
Price/Book 16.81 6.17 5.28
Price/Cash Flow -67.92 262.62 818.73
Prices/Earnings -1.38 116.85 118.49
Price/Sales 23.84 27.44 22.16
Price/FCF -67.92 262.62 818.73
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -7.80 0.39 0.42
Operating Margin 22.64 0.15 0.12
ROA 25.58 < 0.005 < 0.005
ROE 0.01 0.01 18.44
ROIC 0.02 0.01 -19.24
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.09 -0.15 44.30
Dividends QOQ < 0.005 0.01 379.87
EBIT QOQ -0.14 0.16 19.72
EPS QOQ 0.14 0.20 46.67
FCF QOQ -0.82 2.66 225.10
Revenue QOQ -0.09 -0.05 40.59
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 116.84 119.97 2.68
Days Sales Outstanding (DSO) 50.64 49.55 -2.15
Inventory Turnover 0.77 0.75 -2.61
Debt/Capitalization 0.57 0.54 -4.93
Quick Ratio 1.82 1.67 -8.42
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 22.69 22.78 0.42
Cash 3.18 2.38 -25.16
Capex -0.86 -0.44 48.33
Free Cash Flow 0.15 0.54 265.67
Revenue 5.41 5.12 -5.29
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 3.85 3.35 -12.86
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 17.89 18.32 2.42
Naive Interpretation Member
06 - Financial Health · Bad
End of ENTG's Analysis
CIK: 1101302 CUSIP: 29362U104 ISIN: US29362U1043 LEI: - UEI: -
Secondary Listings
ENTG has no secondary listings inside our databases.